Ptc Therapeutics

(NASDAQ) PTCT

Current Price$68.79

Market Cap$5.71B

Since IPO (2013)+323%

5 Year+75%

1 Year+51%

1 Month-3%

Ptc Therapeutics Financials at a Glance

Market Cap

$5.71B

Revenue (TTM)

$827.11M

Net Income (TTM)

$186.73M

EPS (TTM)

$-2.34

P/E Ratio

-29.39

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Price

$68.79

Volume

715,145.06

Open

$69.59

Price

$68.79

Volume

715,145.06

Open

$69.59

Previous Close

$68.81

Daily Range

$68.26 - $70.74

52-Week Range

$43.17 - $87.50

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Price

$68.79

Volume

715,145.06

Open

$69.59

Previous Close

$68.81

Daily Range

$68.26 - $70.74

52-Week Range

$43.17 - $87.50

PTCT News

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing

Jake LerchMar 3, 2026

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million?

Jonathan PoncianoDec 3, 2025

Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You?

Jonathan PoncianoDec 2, 2025

A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000

Cory RenauerNov 29, 2025

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why

Jonathan PoncianoNov 18, 2025

Here's Why Shares in PTC Therapeutics Soared This Week

Lee SamahaSep 5, 2025

PTCT Earnings Beat but Sales Drop 4%

Motley Fool Markets TeamAug 7, 2025

Two people seated at a lab desk featuring a PC screen and microscope

Why PTC Therapeutics Soared 15% Higher Today

Eric VolkmanOct 19, 2023

Page 1

PTCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ptc Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

991

CEO

Matthew B. Klein, MD

Website

www.ptcbio.com

Headquarters

Warren, NJ 07080, US

PTCT Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-8%

Net Income Margin

-23%

Return on Equity

Return on Capital

-3%

Return on Assets

-7%

Earnings Yield

-3.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.71B

Shares Outstanding

82.95M

Volume

715.15K

Avg. Volume

1.23M

Financials (TTM)

Gross Profit

$1.66B

Operating Income

$856.51M

EBITDA

$887.66M

Operating Cash Flow

$711.20M

Capital Expenditure

$8.86M

Free Cash Flow

$702.34M

Cash & ST Invst.

$1.95B

Total Debt

$492.28M

Ptc Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$272.55M

-76.8%

Gross Profit

$232.94M

-80.0%

Gross Margin

85.47%

N/A

Market Cap

$5.71B

N/A

Market Cap/Employee

$6.08M

N/A

Employees

939

N/A

Net Income

$2.81M

-100.3%

EBITDA

$61.30M

-93.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.50B

-8.6%

Accounts Receivable

$219.92M

+4.5%

Inventory

$75.57M

+248.6%

Long Term Debt

$90.07M

-75.9%

Short Term Debt

$305.01M

+1747.3%

Return on Assets

-6.51%

N/A

Return on Invested Capital

-3.48%

N/A

Free Cash Flow

$60.24M

-106.9%

Operating Cash Flow

$59.04M

-106.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TGTXTG Therapeutics, Inc.

TGTXTG Therapeutics, Inc.$38.87-0.94%

ALKSAlkermes plc

ALKSAlkermes plc$36.80-0.41%

PTGXProtagonist Therapeutics, Inc.

PTGXProtagonist Therapeutics, Inc.$99.19-2.76%

ACLXArcellx, Inc.

ACLXArcellx, Inc.$115.07+0.02%

PCVXVaxcyte, Inc.

PCVXVaxcyte, Inc.$47.30-0.19%

MTSRMetsera, Inc.

MTSRMetsera, Inc.$70.50-0.35%

CRNXCrinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.$36.80-0.78%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About PTCT

What is the current price of Ptc Therapeutics?

Ptc Therapeutics is trading at $68.81 per share.

What is the 52-week range for Ptc Therapeutics?

Over the past 52 weeks, Ptc Therapeutics has traded between $43.18 and $87.50.

How much debt does Ptc Therapeutics have?

As of the most recent reporting period, Ptc Therapeutics reported total debt of $395.09M.

How much cash does Ptc Therapeutics have on hand?

Ptc Therapeutics reported $833.99M in cash and cash equivalents in its most recent financial results.

What is Ptc Therapeutics’s dividend yield?

Ptc Therapeutics does not currently have a dividend yield.

Ptc Therapeutics

Ptc Therapeutics Financials at a Glance

PTCT News

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million?

Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You?

A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why

Here's Why Shares in PTC Therapeutics Soared This Week

PTCT Earnings Beat but Sales Drop 4%

Why PTC Therapeutics Soared 15% Higher Today

PTCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ptc Therapeutics

PTCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ptc Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PTCT

What is the current price of Ptc Therapeutics?

What is the 52-week range for Ptc Therapeutics?

How much debt does Ptc Therapeutics have?

How much cash does Ptc Therapeutics have on hand?

What is Ptc Therapeutics’s dividend yield?

Premium Investing Services